Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aminolevulinic acid hydrochloride - Alpheus Medical

Next Previous
X
Search
Drug Profile

Aminolevulinic acid hydrochloride - Alpheus Medical

Alternative Names: 5 Aminolevulinic acid hydrochloride - Alpheus Medical; 5-ALA; 5-ALA HCl; Gleolan

Latest Information Update: 16 Nov 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Alpheus Medical
  • Class Amino acids; Antianaemics; Antineoplastics; Diagnostic agents; Imaging agents; Keto acids; Levulinic acids; Nootropics; Skin disorder therapies; Small molecules; Vascular disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Glioblastoma
  • New Molecular Entity No

Highest Development Phases

  • Phase I Glioblastoma; Glioma

Most Recent Events

  • 10 Nov 2022 Alpheus™ Medical plans to initiate additional clinical trial in Solid tumours (non-brain cancer indications)
  • 13 Jul 2022 Aminolevulinic acid hydrochloride receives Fast Track designation for Glioblastoma [PO] in USA
  • 13 Jul 2022 Aminolevulinic acid hydrochloride receives Orphan Drug status for Glioblastoma in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top